Ophthalmic Pharmacology — MCQs
On this page
Which of the following drugs possesses similar cycloplegic action and is a more potent mydriatic than atropine?
Pilocarpine is the drug of choice in which type of glaucoma?
In atropine instillation, all are seen except:
Latanoprost (a prostaglandin F2 alpha analogue) is used for the treatment of which of the following conditions?
For refraction in a hypermetropic child, which is the best drug?
What is the duration of cycloplegia induced by atropine in an adult?
Which antiglaucoma drug is contraindicated in acute uveitis?
What is the drug of choice for Herpes simplex Endophthalmitis?
Which drug is contraindicated in a patient with narrow-angle glaucoma?
A patient using a contact lens develops a corneal infection. Laboratory diagnosis of acanthamoeba keratitis was established. Which of the following is the best drug for treatment?
Ophthalmic Pharmacology Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following drugs possesses similar cycloplegic action and is a more potent mydriatic than atropine?
- A. Hyoscine (Correct Answer)
- B. Tropicamide
- C. Homatropine
- D. All of the above
Explanation: **Explanation:** The correct answer is **Hyoscine (Scopolamine)**. **Why Hyoscine is the correct answer:** Hyoscine is a belladonna alkaloid that acts as a competitive antagonist at muscarinic receptors. In terms of ocular potency, it is significantly more potent than atropine on a weight-for-weight basis. While it produces a **similar degree of cycloplegia** (paralysis of the ciliary muscle), it is a **more potent mydriatic** (pupillary dilator) than atropine. Its duration of action (3–7 days) is shorter than that of atropine (7–10 days), making it a useful alternative when a potent but slightly shorter-acting cycloplegic is required. **Analysis of Incorrect Options:** * **Tropicamide:** This is the shortest-acting mydriatic (duration 4–6 hours). While it is excellent for fundus examination, its cycloplegic action is much weaker and shorter than atropine. * **Homatropine:** A semi-synthetic derivative that is 10 times less potent than atropine. It has a shorter duration of action (1–3 days) and is primarily used in the treatment of anterior uveitis to prevent synechiae without the prolonged blurriness of atropine. **High-Yield Clinical Pearls for NEET-PG:** * **Potency Order:** Hyoscine > Atropine > Homatropine. * **Duration of Action (Cycloplegia):** Atropine (7–10 days) > Hyoscine (3–7 days) > Homatropine (1–3 days) > Cyclopentolate (24 hours) > Tropicamide (6 hours). * **Drug of Choice:** Atropine is the drug of choice for refraction in children <5 years (due to strong accommodation), while Homatropine/Cyclopentolate is preferred for older children. * **Side Effect:** Systemic absorption of atropine in children can lead to "Atropine flushing," fever, and tachycardia.
Question 2: Pilocarpine is the drug of choice in which type of glaucoma?
- A. Open angle glaucoma
- B. Acute angle closure glaucoma (Correct Answer)
- C. Pigmentary glaucoma
- D. None of the above
Explanation: **Explanation:** **Pilocarpine** is a direct-acting parasympathomimetic (cholinergic agonist) that acts on the muscarinic receptors (M3) of the iris sphincter muscle and the ciliary body. **Why it is the drug of choice for Acute Angle Closure Glaucoma (AACG):** In AACG, the primary goal is to pull the peripheral iris away from the trabecular meshwork to open the drainage angle. Pilocarpine causes **miosis** (pupillary constriction), which physically stretches the iris, thinning it and pulling it out of the angle. This restores the outflow of aqueous humor and rapidly lowers intraocular pressure (IOP). *Note:* In clinical practice, it is typically administered once the IOP has been slightly lowered by systemic agents (like Acetazolamide), as the iris sphincter is often ischemic and non-responsive when IOP is >40-50 mmHg. **Why other options are incorrect:** * **Open Angle Glaucoma:** While Pilocarpine can lower IOP by increasing trabecular outflow, it is no longer a first-line treatment due to side effects like miosis (causing night blindness) and accommodative spasms (brow ache). Prostaglandin analogues and Beta-blockers are preferred. * **Pigmentary Glaucoma:** This is a subtype of open-angle glaucoma. While miotics can reduce iris-zonule friction, they are rarely the "drug of choice" compared to modern medical or laser therapies. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism in AACG:** Miosis → Mechanical opening of the angle. 2. **Side Effects:** Accommodative spasm (pseudomyopia), brow ache, and retinal detachment (due to ciliary body contraction pulling on the retina). 3. **Contraindication:** It should **never** be used in **Uveitic Glaucoma** or Malignant Glaucoma, as it can worsen inflammation and promote posterior synechiae formation. 4. **Pre-Laser:** It is routinely used before Peripheral Iridotomy (LPI) to thin the iris, making the procedure easier.
Question 3: In atropine instillation, all are seen except:
- A. Dilated pupil
- B. Paralysis of accommodation
- C. Increased water content to tear (Correct Answer)
- D. Decreased water content to tear
Explanation: **Explanation:** Atropine is a potent **non-selective muscarinic antagonist** (parasympatholytic). To answer this question, one must understand the parasympathetic nerve supply to the eye and its associated glands. **Why "Increased water content to tear" is the correct answer (the "Except"):** The lacrimal gland is under parasympathetic control (via the facial nerve and pterygopalatine ganglion). Parasympathetic stimulation increases tear production. Since atropine **blocks** muscarinic receptors, it inhibits the lacrimal gland, leading to **decreased** aqueous tear production. Therefore, "increased water content" is physiologically impossible under the influence of atropine; instead, patients often complain of dry eyes. **Analysis of Incorrect Options:** * **A. Dilated pupil:** Atropine blocks the M3 receptors on the **sphincter pupillae** muscle. This results in unopposed action of the dilator pupillae (sympathetic), leading to passive **mydriasis**. * **B. Paralysis of accommodation:** Atropine blocks the M3 receptors on the **ciliary muscle**. This prevents the muscle from contracting, meaning the lens cannot become more convex for near vision. This state is known as **cycloplegia**. * **D. Decreased water content to tear:** As explained above, this is a direct pharmacological effect of anticholinergic drugs on the lacrimal gland. **High-Yield Clinical Pearls for NEET-PG:** * **Potency:** Atropine is the strongest cycloplegic and mydriatic available (effects can last 7–10 days). * **Drug of Choice:** It is the DOC for **iridocyclitis** (to prevent posterior synechiae and provide pain relief by resting the ciliary muscle). * **Contraindication:** Strictly contraindicated in **Primary Narrow-Angle Glaucoma** as it can precipitate an acute attack. * **Systemic Absorption:** In children, always apply pressure over the **lacrimal sac (punctal occlusion)** after instillation to prevent systemic absorption and "atropine toxicity" (flushing, fever, tachycardia).
Question 4: Latanoprost (a prostaglandin F2 alpha analogue) is used for the treatment of which of the following conditions?
- A. Maintaining the patency of the ductus arteriosus
- B. Managing pulmonary hypertension
- C. Protecting the gastric mucosa
- D. Treating glaucoma (Correct Answer)
Explanation: **Explanation:** **Latanoprost** is a synthetic **Prostaglandin F2α (PGF2α) analogue** and is currently considered the first-line medical therapy for Primary Open-Angle Glaucoma (POAG). **1. Why Option D is Correct:** Latanoprost acts as a selective agonist at the **FP receptors** in the eye. Its primary mechanism of action is increasing the **uveoscleral outflow** of aqueous humor (the non-conventional pathway). By enhancing the drainage of fluid through the ciliary muscle into the suprachoroidal space, it effectively lowers intraocular pressure (IOP). **2. Why Other Options are Incorrect:** * **Option A:** Maintaining the patency of the ductus arteriosus is achieved using **Alprostadil (PGE1)**. Conversely, NSAIDs like Indomethacin are used to close a patent ductus. * **Option B:** Pulmonary hypertension is managed using prostacyclin (PGI2) analogues like **Epoprostenol, Treprostinil, or Iloprost**. * **Option C:** Gastric mucosa protection (especially in NSAID-induced ulcers) is the role of **Misoprostol (PGE1 analogue)**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Dosing:** It is administered as a **once-daily** drop (usually at night), which ensures better patient compliance compared to beta-blockers. * **Side Effects (Highly Tested):** * **Increased iris pigmentation:** Permanent darkening of the iris (brown discoloration). * **Hypertrichosis:** Increased length, thickness, and number of eyelashes (trichomegaly). * **Cystoid Macular Edema (CME):** Should be avoided in aphakic or pseudophakic patients. * **Prostaglandin-associated periorbitopathy:** Loss of periorbital fat. * **Contraindication:** Active intraocular inflammation (Uveitis), as prostaglandins are pro-inflammatory mediators.
Question 5: For refraction in a hypermetropic child, which is the best drug?
- A. Phenylephrine
- B. Atropine ointment (Correct Answer)
- C. Atropine drops
- D. Homatropine
Explanation: **Explanation:** In children, especially those with hypermetropia, the ciliary muscle is highly active and has a strong accommodative power. To obtain an accurate refractive error measurement, **cycloplegic refraction** is mandatory to paralyze the ciliary muscle (cycloplegia) and uncover the total hypermetropia (latent + manifest). **Why Atropine Ointment is the Correct Choice:** * **Gold Standard:** Atropine is the most potent cycloplegic available. In children under 7 years (or those with accommodative esotropia), it is the drug of choice because weaker agents cannot fully overcome their intense accommodation. * **Ointment vs. Drops:** In pediatric patients, **ointment (1%)** is preferred over drops. Ointment has better bioavailability, provides a more sustained effect, and, most importantly, **minimizes systemic absorption** through the nasolacrimal duct, thereby reducing the risk of systemic toxicity (e.g., tachycardia, flushing, fever). **Analysis of Incorrect Options:** * **Phenylephrine:** This is a pure sympathomimetic (mydriatic) that dilates the pupil but has **no cycloplegic effect**. It cannot be used for refraction in children. * **Atropine Drops:** While effective, drops carry a higher risk of systemic side effects in children due to rapid drainage into the nose and throat. * **Homatropine:** This is a weaker cycloplegic with a shorter duration. It is insufficient for uncovering latent hypermetropia in young children. **High-Yield Clinical Pearls for NEET-PG:** 1. **Atropine Regimen:** Usually applied 2–3 times daily for 3 days prior to refraction. 2. **Deduction Factor:** When using Atropine for refraction, a deduction of **1.0 Diopter** is made from the objective retinoscopy finding to account for the "tone" of the ciliary muscle. 3. **Cycloplegic of choice by age:** * < 7 years: Atropine (Ointment preferred). * 7–20 years: Homatropine or Cyclopentolate. * > 20 years: Tropicamide. 4. **Antidote:** Physostigmine is the antidote for systemic atropine poisoning.
Question 6: What is the duration of cycloplegia induced by atropine in an adult?
- A. 6 hours
- B. 2-3 days
- C. 7-10 days (Correct Answer)
- D. 1-2 days
Explanation: ### Explanation **Correct Answer: C. 7-10 days** **Mechanism and Rationale:** Atropine is a potent, non-selective muscarinic antagonist. In the eye, it blocks the M3 receptors on the **ciliary muscle** (causing cycloplegia or paralysis of accommodation) and the **sphincter pupillae** (causing mydriasis). Atropine has the strongest binding affinity among all clinical cycloplegics. While its peak effect occurs within hours, its duration of action is prolonged due to its slow dissociation from the receptors and its sequestration in the uveal pigment (melanin). In an adult, the cycloplegic effect typically lasts **7 to 10 days**, while the mydriatic effect can persist for up to 14 days. **Analysis of Incorrect Options:** * **Option A (6 hours):** This is the approximate duration of action for **Tropicamide**, the shortest-acting mydriatic/cycloplegic, making it ideal for routine fundus examinations. * **Option B (2-3 days):** This corresponds to the duration of action for **Homatropine**. It is often used in the treatment of anterior uveitis to prevent synechiae without the prolonged blurriness of atropine. * **Option D (1-2 days):** This is the typical duration for **Cyclopentolate**, which is the drug of choice for cycloplegic refraction in children due to its rapid onset and moderate duration. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Atropine is the drug of choice for refraction in children **under 7 years** of age (especially those with accommodative esotropia) because their ciliary muscle tone is too high for weaker agents. * **Formulation:** In children, **1% Atropine ointment** is preferred over drops to minimize systemic absorption through the nasolacrimal duct, reducing the risk of systemic toxicity (fever, flushing, tachycardia). * **Contraindication:** All mydriatics/cycloplegics are strictly contraindicated in patients with **Primary Angle Closure Glaucoma (PACG)** as they can precipitate an acute attack.
Question 7: Which antiglaucoma drug is contraindicated in acute uveitis?
- A. Pilocarpine (Correct Answer)
- B. Timolol
- C. Brimonidine
- D. Latanoprost
Explanation: **Explanation:** The correct answer is **Pilocarpine**. In acute uveitis, the primary goal of treatment is to rest the ciliary body and prevent the formation of **posterior synechiae** (adhesions between the iris and the lens). * **Pilocarpine** is a miotic (parasympathomimetic). It causes pupillary constriction and ciliary muscle contraction. In an inflamed eye, miosis increases the surface area of contact between the iris and the lens, significantly increasing the risk of **posterior synechiae**. Furthermore, it breaks the blood-aqueous barrier, potentially worsening the intraocular inflammation. Therefore, it is strictly contraindicated. **Analysis of Other Options:** * **Timolol (Beta-blocker):** It reduces aqueous humor production and does not affect pupil size or the blood-aqueous barrier, making it a safe first-line choice for secondary glaucoma in uveitis. * **Brimonidine (Alpha-2 agonist):** It reduces aqueous production and increases uveoscleral outflow. It is generally safe, though it may occasionally cause granulomatous uveitis as a side effect. * **Latanoprost (Prostaglandin Analog):** While some clinicians avoid PGAs in active uveitis due to a theoretical risk of exacerbating inflammation or causing cystoid macular edema (CME), they are **not** as strictly contraindicated as Pilocarpine. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Uveitis:** Atropine (a strong cycloplegic) is used to "put the eye to rest" and prevent synechiae. * **Avoid in Uveitic Glaucoma:** Pilocarpine (due to synechiae) and Carbonic Anhydrase Inhibitors (relative contraindication if there is corneal endothelial compromise). * **Inverse Relationship:** Miotics (Pilocarpine) worsen uveitis; Mydriatics/Cycloplegics (Atropine) treat uveitis.
Question 8: What is the drug of choice for Herpes simplex Endophthalmitis?
- A. Acyclovir (Correct Answer)
- B. Vidarabine
- C. Amantidine
- D. Interferon
Explanation: **Explanation:** **Acyclovir** is the drug of choice for Herpes Simplex Virus (HSV) infections of the eye, including endophthalmitis and keratitis. Its mechanism of action involves selective inhibition of viral DNA polymerase. It acts as a prodrug that requires phosphorylation by viral **thymidine kinase** to become active (Acyclovir triphosphate), ensuring high selectivity for infected cells and a superior safety profile compared to older antivirals. **Analysis of Options:** * **B. Vidarabine:** An older antiviral that was used for HSV keratitis. However, it is significantly more toxic to the corneal epithelium and less effective than Acyclovir. It is now largely obsolete in clinical practice. * **C. Amantadine:** This is an anti-influenza agent (specifically Influenza A) and is also used in Parkinson’s disease. It has no clinical efficacy against the Herpesviridae family. * **D. Interferon:** While interferons have antiviral properties and can be used as adjuvant therapy in resistant cases of dendritic ulcers, they are not the primary drug of choice for acute HSV endophthalmitis due to inconsistent results and side effects. **High-Yield Clinical Pearls for NEET-PG:** * **HSV Keratitis:** Characterized by **dendritic ulcers** with terminal bulbs. These stain with Rose Bengal (dead cells at the margin) and Fluorescein (the ulcer base). * **Steroid Contraindication:** Topical steroids are strictly contraindicated in the presence of an active epithelial dendritic ulcer as they can lead to **Geographic ulcers**. * **DOC for CMV Retinitis:** Ganciclovir (Valganciclovir is the oral DOC). * **DOC for HZO (Herpes Zoster Ophthalmicus):** Oral Acyclovir (800mg 5x daily), started within 72 hours of rash onset.
Question 9: Which drug is contraindicated in a patient with narrow-angle glaucoma?
- A. Acetazolamide
- B. Timolol
- C. Homatropine (Correct Answer)
- D. Pilocarpine
Explanation: **Explanation:** **Why Homatropine is the Correct Answer:** Homatropine is a **mydriatic-cycloplegic** drug (an anticholinergic). In patients with a pre-existing narrow anterior chamber angle, inducing mydriasis (dilation of the pupil) causes the peripheral iris tissue to bunch up and crowd the angle of the anterior chamber. This further obstructs the trabecular meshwork, blocking the outflow of aqueous humor. This can precipitate an **acute attack of Angle-Closure Glaucoma**, which is a sight-threatening emergency. Therefore, all strong mydriatics (Atropine, Homatropine, Cyclopentolate) are strictly contraindicated in narrow-angle glaucoma. **Analysis of Incorrect Options:** * **Acetazolamide (Option A):** A Carbonic Anhydrase Inhibitor that reduces aqueous production. It is actually a first-line treatment for managing acute angle-closure glaucoma. * **Timolol (Option B):** A non-selective Beta-blocker that decreases aqueous humor secretion. It is commonly used to lower intraocular pressure in various types of glaucoma. * **Pilocarpine (Option D):** A miotic (parasympathomimetic). It causes pupillary constriction, which pulls the iris away from the angle, opening the drainage pathway. It is the **drug of choice** for the initial management of acute angle-closure glaucoma. **High-Yield Clinical Pearls for NEET-PG:** * **Mydriatics** (e.g., Homatropine) are **contraindicated** in narrow-angle glaucoma but are used in inflammatory conditions like iridocyclitis to prevent synechiae. * **Miotics** (e.g., Pilocarpine) are **contraindicated** in inflammatory glaucoma (uveitic glaucoma) as they may increase the risk of posterior synechiae. * **Gold Standard Treatment** for Angle-Closure Glaucoma: Definitive treatment is **Peripheral Iridotomy** (usually via Nd:YAG laser).
Question 10: A patient using a contact lens develops a corneal infection. Laboratory diagnosis of acanthamoeba keratitis was established. Which of the following is the best drug for treatment?
- A. Propamidine
- B. Neosporin
- C. Ketoconazole
- D. Polyhexamethylene biguanide (Correct Answer)
Explanation: **Explanation:** **Acanthamoeba keratitis** is a vision-threatening infection typically associated with contact lens wearers (often due to poor hygiene or use of tap water). The organism exists in two forms: the active **trophozoite** and the highly resistant **double-walled cyst**. **1. Why Polyhexamethylene Biguanide (PHMB) is the Correct Answer:** PHMB (0.02%) is considered the first-line treatment because it is a **biguanide** with potent cysticidal activity. It acts by disrupting the cytoplasmic membrane of the organism. Unlike many other agents, biguanides (PHMB and Chlorhexidine) can effectively penetrate and kill the dormant cyst stage, which is crucial for preventing recurrence. **2. Analysis of Incorrect Options:** * **Propamidine (Brolene):** This is a diamidine. While it was historically the treatment of choice, it is less effective than PHMB when used as monotherapy and is associated with significant corneal toxicity. It is now often used as an adjuvant rather than the primary drug. * **Neosporin:** This is a combination of Neomycin, Polymyxin B, and Bacitracin. While Neomycin has some anti-acanthamoebic activity, it is insufficient to treat the infection alone and is primarily used to prevent secondary bacterial infections. * **Ketoconazole:** This is an antifungal. While systemic or topical antifungals (like Voriconazole) are sometimes used as adjuncts in refractory cases, they are not the primary treatment for Acanthamoeba. **3. High-Yield Clinical Pearls for NEET-PG:** * **Classic Presentation:** Severe ocular pain that is **"out of proportion"** to the clinical signs. * **Pathognomonic Sign:** **Radial Keratoneuritis** (infiltration along corneal nerves). * **Late Sign:** Ring-shaped corneal infiltrate. * **Gold Standard Culture:** Non-nutrient agar (NNA) seeded with *E. coli*. * **Stains:** Calcofluor white (fluorescent) or Periodic acid-Schiff (PAS).
Practice by Chapter
Ocular Pharmacokinetics
Practice Questions
Anti-infective Agents
Practice Questions
Anti-inflammatory Drugs
Practice Questions
Antiglaucoma Medications
Practice Questions
Mydriatics and Cycloplegics
Practice Questions
Ocular Lubricants
Practice Questions
Anti-VEGF Agents
Practice Questions
Ocular Diagnostic Agents
Practice Questions
Anesthetics in Ophthalmology
Practice Questions
Preservatives and Their Effects
Practice Questions
Ocular Toxicology
Practice Questions
Novel Drug Delivery Systems
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free